Given Imaging has granted US marketing rights for the PillCam ESO 2 to Johnson & Johnson (NYSE: JNJ) subsidiary Ethicon Endo-Surgery’s InScope division. Marketing is expected to begin by year-end.
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments